Astec LifeSciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, sales was INR 4,045.84 million compared to INR 3,829.51 million a year ago. Revenue was INR 4,082.47 million compared to INR 3,893.24 million a year ago. Net income was INR 468.04 million compared to INR 410.89 million a year ago. Basic earnings per share from continuing operations was INR 23.89 compared to INR 21 a year ago. Diluted earnings per share from continuing operations was INR 23.88 compared to INR 20.97 a year ago.